주식 시장 뉴스
최신 금융 뉴스 · 업데이트 7월 11, 2026
J&J Phase 1b/2 OrigAMI-4: Subcutaneous Amivantamab Shows 42% ORR In Head & Neck Cancer
Johnson & Johnson's amivantamab showed promising results with a 42% ORR in heavily pretreated head and neck cancer, but further …
"자금력이 탄탄한" NGO, 뉴어크 반 ICE 혼란 배후; 베센트, 비영리 단체 단속 신호
"Well-Funded" NGO Machine Behind Newark Anti-ICE Chaos; Bessent Signals Nonprofit Crackdown
The panel discusses potential impacts of IRS guidance on nonprofits tied to activism, with risks including capital flight, reputational damage, …
2 Space Stocks to Buy Before the SpaceX IPO on June 12
The panel consensus is bearish on AST SpaceMobile (ASTS) and Intuitive Machines (LUNR), citing significant execution risks, uncertain revenue visibility, …
$1,000로 구매할 최고의 암호화폐
The Best Cryptocurrency to Buy With $1,000 Right Now
The panel is divided on Solana's investment merit, with concerns about repeated outages, unclear ETF timeline, and intense competition from …
Nvidia Recently Plowed $3.8 Billion Into These 2 Artificial Intelligence (AI) Stocks
Despite strategic positioning in AI infrastructure, Nvidia's investments in CoreWeave and Coherent pose significant risks, including high leverage, potential dilution, …
퇴직 후 일할 때 반드시 알아야 할 사회 보장 근무 규칙
Social Security Work Rules You Must Understand Before Working in Retirement
The panel generally agreed that while working in retirement can potentially increase Social Security benefits, the current system presents significant …
Pfizer's BRAFTOVI Combo Nearly Doubles PFS In BRAF V600E Metastatic Colorectal Cancer
Pfizer's BREAKWATER Cohort 3 data shows promising results in first-line BRAF V600E mCRC, with a significant PFS benefit and encouraging …
Eli Lilly의 Retevmo Phase 3 LIBRETTO-432는 RET+ 조기 NSCLC에서 재발 위험을 83% 감소시킵니다.
Eli Lilly's Retevmo Phase 3 LIBRETTO-432 Cuts Recurrence Risk 83% In RET+ Early-Stage NSCLC
Eli Lilly's selpercatinib (Retevmo) showed promising results in a Phase 3 trial, reducing recurrence risk by 83% in early-stage RET-positive …
최고 주식과 함께 희귀한 매수 기회가 여기 있을 수 있습니다
A Rare Buying Opportunity May Be Here With This Top Stock
Despite strong fundamentals like 75% recurring revenue and 17% procedure growth, the panel is cautious due to high valuation (51x …
SoundHound AI 주식 가격이 지난 6개월 동안 29% 하락 – 그렇다면 왜 여전히 장기 매수 관점일 수 있을까요?
SoundHound AI's Stock Price Is Down 29% in the Last 6 Months -- Here's Why It Still Could Be a Long-Term Buy
The panel consensus is bearish on SoundHound's planned acquisition of LivePerson, citing immediate dilution, unproven synergies, high integration risk, and …
이 AI 하드웨어 병목 현상이 차세대 1조 달러 규모의 기술 기업을 결정짓고 있습니다.
This AI Hardware Bottleneck Is Determining the Next Trillion-Dollar Tech Companies
The panel generally agrees that while AI is driving demand for memory, the cyclical nature of the industry and potential …
영국에서 이동 중 모바일 신호 액세스에 어려움을 겪는 사람 10명 중 4명
Four in 10 struggle to access mobile signal on the move in the UK
The UK's mobile connectivity issues stem from uneven rollout favoring urban areas and congestion in city centers. While government initiatives …